Associated with an BCL2 expression, the most frequently observed recurrent cytogenetic abnormality by interphase fluorescence in situ hybridization (iFISH) in patients with AL amyloidosis (40–50%) is t(11;14), more frequently than in patients with PCM (15–20%) [13]. This evidence concerns the gene BCL2 and AL amyloidosis.